Jefferies Financial Group’s Cabaletta Bio CABA Stock Holding History

Jefferies Financial Group’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,442	Closed	-$90K	–	1689
2026 Q1	$90K	Sell	33,442 -11,683	-26%	-$32.4K	﹤0.01%	1609
2025 Q4	$98.8K	Sell	45,125 -2,375	-5%	-$5.88K	﹤0.01%	1703
2025 Q3	$111K	Sell	47,500 -1,949,708	-98%	-$3.35M	﹤0.01%	1329
2025 Q2	$3.04M	Buy	+1,997,208	New	+$3.11M	0.03%	426
2023 Q1	–	Sell	-25,000	Closed	-$231K	–	1654
2022 Q4	$231K	Buy	+25,000	New	+$91K	﹤0.01%	1262

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jefferies Financial Group's CABA Position: Q2 2026 in Review

Jefferies Financial Group sold out of Cabaletta Bio (CABA) in Q2 2026, closing a stake of 33,442 shares — an estimated $90K sold.

Jefferies Financial Group first reported a position in CABA in Q4 2022 and held it in 5 quarters. The position peaked at $3.04M in Q2 2025. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Jefferies Financial Group reported no remaining Cabaletta Bio position as of Q2 2026 after selling out during the quarter.
Jefferies Financial Group sold 33,442 Cabaletta Bio shares in Q2 2026, an estimated $90K.
Jefferies Financial Group first reported a position in Cabaletta Bio in Q4 2022 and held it in 5 quarters.
Jefferies Financial Group's Cabaletta Bio position peaked at $3.04M in Q2 2025.
139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.